Literature DB >> 16394844

HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.

John R Koeppe1, Thomas B Campbell, Eric L Rapaport, Cara C Wilson.   

Abstract

OBJECTIVES: To determine whether increased sequence variation occurs in regions of endogenous HIV-1 targeted by HIV-1-specific CD4 T cells. The presence of increased variation would be suggestive of immune evasion by HIV-1.
DESIGN: We performed a cross-sectional study of untreated HIV-1-infected subjects measuring HIV-1-specific interferon (IFN)-gamma-secreting CD4 T-cell responses against epitopes in Gag p17 and p24 and concurrent endogenous plasma HIV-1 RNA epitope sequence variation.
METHODS: CD8- depleted IFNgamma enzyme-linked immunospot assays were used to identify regions of HIV-1 Gag recognized by CD4 T cells. Reverse transcriptase polymerase chain reaction and TA cloning were used to sequence endogenous plasma HIV-1 virus and identify variants.
RESULTS: CD4 T-cell epitopes in Gag p17 and p24 were identified in 5 individuals, and concurrent sequence information on endogenous HIV-1 was obtained in 4 of these individuals. Endogenous plasma HIV-1 RNA sequencing revealed no intrapatient amino acid sequence variation through identified epitopes.
CONCLUSIONS: In these chronically infected viremic subjects, circulating IFNgamma-secreting CD4 T-cell responses were directed against epitope sequences found in the predominant strain of endogenous circulating plasma HIV-1, suggesting that escape from CD4 T-cell responses is not a common process in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394844     DOI: 10.1097/01.qai.0000195608.32885.38

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.

Authors:  Jaclyn K Wright; Zabrina L Brumme; Boris Julg; Mary van der Stok; Zenele Mncube; Xiaojiang Gao; Jonathan M Carlson; Philip J R Goulder; Bruce D Walker; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.

Authors:  Eli Boritz; Eric L Rapaport; Thomas B Campbell; John R Koeppe; Cara C Wilson
Journal:  Virology       Date:  2006-12-13       Impact factor: 3.616

3.  Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations.

Authors:  R Brad Jones; Feng-Yun Yue; Xiao Xiao Jenny Gu; Diana V Hunter; Shariq Mujib; Gabor Gyenes; Rosemarie D Mason; Ruqaya Mohamed; Kelly S MacDonald; Colin Kovacs; Mario A Ostrowski
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

4.  CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller.

Authors:  Benjamin J Burwitz; Juan Pablo Giraldo-Vela; Jason Reed; Laura P Newman; Alexander T Bean; Francesca A Nimityongskul; Philip A Castrovinci; Nicholas J Maness; Enrique J Leon; Richard Rudersdorf; Jonah B Sacha
Journal:  Retrovirology       Date:  2012-11-06       Impact factor: 4.602

5.  Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.

Authors:  Karen S Korsholm; Ingrid Karlsson; Sheila T Tang; Lea Brandt; Else Marie Agger; Claus Aagaard; Peter Andersen; Anders Fomsgaard
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

6.  HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.

Authors:  Nathan Erdmann; Victor Y Du; Jonathan Carlson; Malinda Schaefer; Alexander Jureka; Sarah Sterrett; Ling Yue; Dario Dilernia; Shabir Lakhi; Jianming Tang; John Sidney; Jill Gilmour; Susan Allen; Eric Hunter; Sonya Heath; Anju Bansal; Paul A Goepfert
Journal:  PLoS Pathog       Date:  2015-08-24       Impact factor: 6.823

7.  Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination.

Authors:  Mathieu Surenaud; Monica Montes; Cecilia S Lindestam Arlehamn; Alessandro Sette; Jacques Banchereau; Karolina Palucka; Jean-Daniel Lelièvre; Christine Lacabaratz; Yves Lévy
Journal:  PLoS Pathog       Date:  2019-09-09       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.